Roth Capital Starts Antares Pharma (AIS) at Buy

April 12, 2011 10:15 AM EDT
Get Alerts AIS Hot Sheet
Price: $69.55 -0.42%

Rating Summary:
    3 Buy, 0 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 18 | Down: 23 | New: 3
Join SI Premium – FREE
Roth Capital initiates coverage on Antares Pharma (NYSE: AIS) with a Buy rating and 43.50 price target.

For more ratings news on Antares Pharma click here and for the rating history of Antares Pharma click here.

Shares of Antares Pharma closed at $1.58 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

New Coverage

Related Entities

Roth Capital